Northern Trust’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-455,464
Closed -$18.8M 4385
2015
Q2
$18.8M Sell
455,464
-250,554
-35% -$8.98M 0.01% 1639
2015
Q1
$24.9M Buy
706,018
+74,036
+12% +$2.5M 0.01% 1405
2014
Q4
$20.3M Sell
631,982
-5,065
-0.8% -$146K 0.01% 1533
2014
Q3
$17.9M Buy
637,047
+205,641
+48% +$6.26M 0.01% 1593
2014
Q2
$13M Sell
431,406
-242,922
-36% -$6.71M ﹤0.01% 1840
2014
Q1
$18.7M Buy
674,328
+175,987
+35% +$4.6M 0.01% 1630
2013
Q4
$12.7M Sell
498,341
-17,887
-3% -$551K ﹤0.01% 1910
2013
Q3
$15.4M Sell
516,228
-12,251
-2% -$341K 0.01% 1682
2013
Q2
$15.2M Buy
+528,479
New +$14.6M 0.01% 1592

Other funds holding BRLI

Northern Trust's BRLI Position: Q3 2015 in Review

Northern Trust sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 455,464 shares — an estimated $18.8M sold.

Northern Trust first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $24.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Northern Trust reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Northern Trust sold 455,464 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $18.8M.
  • Northern Trust first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Northern Trust's BIO-REFERENCE LABS INC-NEW- position peaked at $24.9M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Northern Trust's 13F filing for Q3 2015, filed 12 Nov 2015.